Asensus Surgical, Inc. (ASXC)

0.2750 +0.0040 (+1.48%) At close: 04:00PM EDT

Asensus Surgical, Inc.

1 TW Alexander Drive
Suite 160
Durham, NC 27703
United States
919 765 8400
https://www.asensus.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 207

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Anthony Fernando	President, CEO & Director	901.03k	N/A	1972
Mr. Shameze Rampertab B.Sc. MBA, CA, CPA	Executive VP & CFO	511.25k	N/A	1967
Mr. Joshua B. Weingard	Chief Legal Officer & Secretary	N/A	N/A	1973
Mr. Paul Ziegler Jr., J.D.	Vice President of Sales	N/A	N/A	1974
Mr. Ethan Loiselle	Vice President of Global Marketing	N/A	N/A	N/A
Ms. Amanda Owens	Vice President of People	N/A	N/A	N/A
Mr. Ravi Kommineni	Head of Global Quality & Regulatory	N/A	N/A	N/A
Mr. Motti Frimer	Vice President of R&D, Digital Solutions and MD of Asensus Surgical	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Corporate governance

Asensus Surgical, Inc.’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 10; Board: 6; Shareholder rights: 3; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.